
Ranbaxy gets shareholders nod for securities issue to Daiichi
Pharmaceutical firm Ranbaxy Laboratories on Tuesday said it has received shareholders approval for allotment of over 7 crore securities to Japanese drug maker Daiichi Sankyo.
The shareholders of the company at the extra ordinary general meeting held today approved the allotment of 46,258,063 equity shares and 23,834,333 warrants to Daiichi Sankyo company on preferential basis, Ranbaxy said in a filing to the Bombay Stock Exchange.
Ranbaxy would issue over 4.62 crore equity shares at Rs 737 each and over 2.38 crore warrants convertible into one equity share of Rs 737 a piece, the company added.
Recently, Ranbaxy had announced that the promoters has signed a share purchase agreement with Daiichi Sankyo to sell off their entire stake of 34.8 per cent in the company to the Japanese firm for Rs 9,576.14 crore.
Meanwhile, the Japanese drug firm, has made an open offer to pick up a further 20 per cent stake in the domestic pharma major for up to Rs 6,818.65 crore.
On completion of the acquisition, the board of directors of the company would be re-constituted to comprise 10 members, of which a combination four independent and non-independent directors would be nominated by Ranbaxy, while the rest six would be named by Daiichi Sankyo.
Shares of Ranbaxy were down over 7 per cent and was quoted at Rs 442.40 in morning trade on the Bombay Stock Exchange.

RBI proposes stricter norms for non-banks

Markets skid amid weak global cues

CSR offences by firms now a ‘civil wrong’, not a crime

Intel tumbles after new CEO recommits to chip manufacturing
- Keeping chip production in-house may be bad for Intel because its manufacturing technology has fallen behind Taiwan Semiconductor Manufacturing Co., which makes chips for many of Intel’s rivals. If the US company can’t catch up, its products will become less competitive, lose sales and market share.

Indigo Paints IPO garners robust response; subscribed 117 times on final day

India will be role model on how to vaccinate billion people at scale: Nilekani

Govt has pledged strict foreign investment rules for e-commerce, says CAIT

Iran starts ramping up oil production to pre-sanctions levels
- Iran has been subject to tough US sanctions since 2018, when the administration of then-President Donald Trump unilaterally withdrew from an international deal that restricted the Middle Eastern country’s nuclear activities. Its crude production was below 2 million barrels a day for most of 2020.

Elon Musk targets telecom for next disruption with Starlink internet

Sensex tanks 746 points; Nifty ends below 14,375

Google parent-company shutting Loon, balloon-based alternative to cell towers

How traditional finance management methods by women continue to be relevant now

Airbus slows production ramp-up, cites virus hit to demand

Bajaj Finance can absorb a surge in provisions, says S&P Global Ratings
